When conducting PMCF, the manufacturer shall proactively collect and evaluate clinical data from the use in or on humans of a device which bears the CE marking and is placed on the market or put into service within its intended purpose as referred to in the relevant conformity assessment procedure, with the aim of confirming the safety and performance throughout the expected lifetime of the device, of ensuring the continued acceptability of identified risks and of detecting emerging risks on the basis of factual evidence.
Agus é i mbun MLCI, déanfaidh an monaróir sonraí cliniciúla a bhailiú agus meastóireacht a dhéanamh orthu go réamhghníomhach, ar sonraí iad ó úsáid feiste, i ndaoine nó ar dhaoine, ar feiste í a bhfuil an mharcáil CE uirthi, agus a chuirtear ar an margadh nó a chuirtear i seirbhís faoin gcríoch a beartaíodh di dá dtagraítear sa nós imeachta ábhartha um measúnú comhréireachta, agus é mar aidhm ag an monaróir sábháilteacht agus feidhmíocht na feiste ar feadh a saolré ionchasaí a chinntiú, inghlacthacht leantach na rioscaí sainaitheanta a áirithiú agus rioscaí atá ag teacht chun cinn a bhrath ar bhonn fianaise fhíorasach.